Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Circulating H3K27 Methylated Nucleosome Plasma Concentration

Wednesday, August 16, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a paper titled 'Circulating H3K27 Methylated Nucleosome Plasma Concentration' by Grolleau et al., published in Biomolecules 2023. It emphasizes the synergistic information gained from combining this analysis with circulating tumor DNA profiling. The findings suggest significant implications for cancer diagnostics and prognostics.
Price reaction · baseline $24.2 (2023-08-16T14:17:00.000Z) · hit during market hours · clean, no other VNRX news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • The study provides new insights into cancer diagnostics.
  • It highlights the prognostic value of the Nu.Q® Cancer Test.
  • The research contributes to understanding chromatin accessibility in sepsis.

Full Press Release Details

Paper titled: Circulating H3K27 Methylated Nucleosome Plasma Concentration: Synergistic Information with Circulating Tumor DNA Molecular Profiling
Grolleau et al 2023
Published in Biomolecules 2023

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the focus of the study by Grolleau et al.?

The study focuses on circulating H3K27 methylated nucleosome plasma concentration and its implications for cancer diagnostics.

Where was the paper published?

The paper was published in the journal Biomolecules in 2023.

What does the study reveal about the Nu.Q® Cancer Test?

The study reveals the prognostic value of the Nu.Q® Cancer Test in cancer diagnostics.

How does the study relate to circulating tumor DNA?

It highlights the synergistic information obtained by combining H3K27 analysis with circulating tumor DNA profiling.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare cancer diagnostics Nu.Q® Cancer Test circulating tumor DNA chromatin accessibility
Last updated: Aug 16, 2023

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk